Abbott Targets Growth in Emerging Markets with CFR Pharmaceuticals Acquisition
By Heather Cartwright
Pharma Deals Review: Vol 2014 Issue 6 (Table of Contents)
Published: 14 Jun-2014
DOI: 10.3833/pdr.v2014.i6.2042 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In order to expand its generics business in fast-growing Latin American markets, Abbott has agreed to acquire Chile’s CFR Pharmaceuticals for US$2...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018